Mental Health

An experimental drug for OCD

The study seeks to explore the benefits of an experimental drug as a potential new treatment of obsessive-compulsive disorder (OCD). The experimental drug changes activity in brain areas believed to be involved in OCD.

This study will involve approximately 8-10 weeks of study participation, including eight weeks of investigational treatment.

Primary disease category:

Secondary disease category(ies):

Emotional State and Personality: A Proof-of-Concept Model for Predicting Performance Under Stress

The SCAN Lab is conducting a study at the University of Arizona to look at how personality traits and emotional responses during stress can influence performance on cognitive tasks.

Primary disease category:

Traumatic Stress Study

The SCAN Lab is conducting a study at the University of Arizona to observe how a six-week course of light exposure influences the brain and sleep pattern in people living with traumatic stress.

For more information about the study and/or to find out if you are eligible, please visit our website and click on the ’Traumatic Stress Study’ link to fill out an online interest form. If you have additional questions, please give us a call at (520) 428-5141.

Primary disease category:

Secondary disease category(ies):

Sleep Disorders